Two LRF-funded Researchers Earn ASH Award

Researchers’ work currently being funded by the Leukemia Research Foundation.

NORTHFIELD, Ill., December 11, 2018 – The Leukemia Research Foundation congratulates Esther Obeng, M.D., Ph.D., Assistant Member, St. Jude Children's Research Hospital, and Russell Ryan, M.D., Assistant Professor at University of Michigan Medicine for earning the 2019 Scholar Award from the American Society of Hematology (ASH). The Scholar Award, one of ASH’s most prestigious, provides $150,000 for junior faculty scholars over a two- to three-year period. The funding helps promising hematologists make the difficult transition from postdoctoral researchers to independent investigators. This is a critical time in the career of this niche of New Investigators, whose research projects represent ground-breaking discoveries that could lead to significant breakthroughs in blood cancer science, at a time when they are trying to establish their own labs. Learn more about the Scholar Award here.

“Providing grants to New Investigators is critically important to facilitating ground-breaking blood cancer research,” said Leukemia Research Foundation Executive Director Kevin Radelet. Grants from the Leukemia Research Foundation not only advance blood cancer science but also jumpstarts careers for these scientists, helping them to continue their important work by earning additional support from large funding sources such as the National Institutes of Health (NIH) and ASH. This is exactly the desired outcome of our research funding program and we are proud to support doctors Obeng and Ryan.”

Both doctors are currently being funded by $100,000, one-year grants from the Leukemia Research Foundation’s Hollis Brownstein Research Grants Program. Information about Dr. Obeng’s research project titled Uncovering how SF3B1 and TET2 mutations cooperate to develop aggressive MDS, and Dr. Ryan’s research project titled Identifying Unique /myc Enhancer Dependencies in B-Lymphoblastic Leukemia, can be found on the Leukemia Research Foundation’s website here.

For more information about the Leukemia Research Foundation and its Hollis Brownstein Research Grants Program, which is currently accepting letters of intent for the 2019-2020 funding years, click here.

 About The Leukemia Research Foundation (LRF)

The Leukemia Research Foundation, headquartered in Northfield, Ill., is committed to funding research and providing support to people affected by blood cancers. The Leukemia Research Foundation is dedicated to conquering all blood cancers by funding research into their causes and cures, and enriching the quality of life of those touched by these diseases. For 72 years, thousands of volunteers and 22 chapters have helped the Foundation raise more than $77 million to help fund research specifically targeting aspiring, eager, and innovative scientists and physicians around the world.

Leukemia Research Foundation information is available at, or by calling 847-424-0600.



For additional information call:
Carl Alston, Director of Communications
847.919.6250 office
630.202.8294 mobile

Category Tag(s): Current News